A cost-utility analysis of therapy for amblyopia
Authors:
- Melissa M BrownMBMelissa M Brown
- Gary C BrownGBGary C Brown
- Sanjay SharmaSSSanjay Sharma
- George R BeauchampGBGeorge R Beauchamp
- 1 December 2002
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 109 (12) , 2265-2271
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- AmblyopiaBritish Journal of Ophthalmology, 2000
- Antiviral Therapies for Herpes Zoster InfectionsPharmacoEconomics, 2000
- INCREMENTAL COST-EFFECTIVENESS OF LASER THERAPY FOR CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH HISTOPLASMOSISRetina, 2000
- The efficacy of occlusion for strabismic amblyopia. Can an optimal duration be identified?British Journal of Ophthalmology, 2000
- Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait timeOphthalmology, 1998
- Pediatric cataractsCurrent Opinion in Ophthalmology, 1997
- Compliance in amblyopia therapy: objective monitoring of occlusion.British Journal of Ophthalmology, 1995
- When is it safe to stop patching?British Journal of Ophthalmology, 1990
- Patients’ Preferences in Randomized Clinical TrialsNew England Journal of Medicine, 1984
- Adding Insult to InjuryNew England Journal of Medicine, 1983